Abcombi representatives completed the February-March
2017 I-Corps at NIH program in which we refined the
company’s strategy for our influenza therapeutic.
Abcombi took home $50,000 during at the conclusion
of the Critical Path Accelerator Program
Abcombi has been announced as a 2016 Finalist for
the 43North Business Plan Competition.
Abcombi Biosciences pitched at the Bright Buffalo
Niagara Entrepreneur Expo and took home the
grand prize of $20,000.